Spatial and single-cell multi-omics reveal pro-angiogenic THY1⁺ fibroblast subtypes predicting prognosis in prostate cancer

This publication has 76 references indexed in Scilit:

• Prostate Cancer
  JAMA, 2025
• Integration Analysis of Single‐Cell Multi‐Omics Reveals Prostate Cancer Heterogeneity
  Advanced Science, 2024
• Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction
  Clinical and Translational Medicine, 2024
• Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing
  Journal of Cancer Research and Clinical Oncology, 2023
• Fibroblast heterogeneity in prostate carcinogenesis
  Cancer Letters, 2021
• A distinct repertoire of cancer‐associated fibroblasts is enriched in cribriform prostate cancer
  The Journal of Pathology: Clinical Research, 2021
• Fibroblast growth factor‐2, derived from cancer‐associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling
  Molecular Carcinogenesis, 2020
• Multiple roles of CD90 in cancer
  Tumor Biology, 2016
• Differential Inductive Signaling of CD90+ Prostate Cancer-Associated Fibroblasts Compared to Normal Tissue Stromal Mesenchyme Cells
  Cancer Microenvironment, 2011
• Tumor‐promoting phenotype of CD90^hi prostate cancer‐associated fibroblasts
  The Prostate, 2009